Preservation of Garnet Growth Zoning and the Duration of Prograde Metamorphism

Chemically zoned garnet growth and coeval modification of this zoning through diffusion are calculated during prograde metamorphic heating to temperatures of up to 850°C. This permits quantification of how the preservation or elimination of zoning profiles in garnet crystals of a given size is sensitive to the specific burial and heating (P-T) path followed, and the integrated duration spent at high temperature (dT/dt). Slow major element diffusion in garnet at T 30 Myr at amphibolite-grade conditions, but small-scale (tens of micrometres) zoning features will be lost early in the prograde stage unless this is ‘rapid' (5 Myr for rocks reaching c. 600°C). Calculations indicate that preservation of unmodified growth compositions in even relatively large (up to 3 mm diameter) pelitic garnet crystals requires prograde and exhumational events to be <10 Myr for rocks reaching c. 600°C. This timescale can be 5 Myr for garnet in rocks reaching 650°C or hotter. It is likely, therefore, that most natural prograde-zoned crystals record compositions already partially re-equilibrated between the time of crystal growth and of reaching maximum temperature. However, a large T-t window exists within which crystals begin to lose their growth compositions but retain evidence of crystal-scale zoning trends that may still be useful for thermobarometry purposes. The upper limit of this window for 500 μm diameter crystals can be as much as several tens of millions of years of heating to c. 700°C. Absolute re-equilibration timescales can be significantly different for garnet growing in different rock compositions, with examples of a granodiorite and a pelite give

Marine Biodiversity and Ecosystem Health of Ilhas Selvagens, Portugal

In September 2015, National Geographic's Pristine Seas project, in conjunction with the Instituto Universitário-Portugal, The Waitt Institute, the University of Western Australia, and partners conducted a comprehensive assessment of the rarely surveyed Ilhas Selvagens to explore the marine environment, especially the poorly understood deep sea and open ocean areas, and quantify the biodiversity of the nearshore marine environment

(±)-trans-3-Oxo-1,2,3,4,4a,9,10,10a-octa­hydro­phenanthrene-10a-carboxylic acid: catemeric hydrogen bonding in a δ-keto acid

The title compound, C15H16O3, aggregates as hydrogen-bonded catemers progressing from each carboxyl to the ketone of a screw-related neighbor [O⋯O = 2.6675 (14) Å and O—H⋯O = 170°]. Two parallel centrosymmetrically related single-strand hydrogen-bonding helices proceed through the cell in the b-axis direction. The packing includes three inter­molecular C—H⋯O=C close contacts, involving both the ketone and the carboxyl group. The structure is isomorphous with that of the previously described Δ4 α,β-unsaturated ketone

Extreme asteroids in the Pan-STARRS 1 Survey

Using the first 18 months of the Pan-STARRS 1 survey we have identified 33 candidate high-amplitude objects for follow-up observations and carried out observations of 22 asteroids. 4 of the observed objects were found to have observed amplitude $A_{obs}\geq 1.0$ mag. We find that these high amplitude objects are most simply explained by single rubble pile objects with some density-dependent internal strength, allowing them to resist mass shedding even at their highly elongated shapes. 3 further objects although below the cut-off for 'high-amplitude' had a combination of elongation and rotation period which also may require internal cohesive strength, depending on the density of the body. We find that none of the 'high-amplitude asteroids' identified here require any unusual cohesive strengths to resist rotational fission. 3 asteroids were sufficiently observed to allow for shape and spin pole models to be determined through light curve inversion. 45864 was determined to have retrograde rotation with spin pole axes $\lambda=218\pm 10^{\circ}, \beta=-82\pm 5^{\circ}$ and asteroid 206167 was found to have best fit spin pole axes $\lambda= 57 \pm 5^{\circ}$, $\beta=-67 \pm 5^{\circ}$. An additional object not initially measured with $A_{obs}>1.0$ mag, 49257, was determined to have a shape model which does suggest a high-amplitude object. Its spin pole axes were best fit for values $\lambda=112\pm 6^{\circ}, \beta=6\pm 5^{\circ}$. In the course of this project to date no large super-fast rotators ($P_{rot} < 2.2$ h) have been identified.Comment: 31 pages; accepted by A

Changes to DPPC domain structure in the presence of carbon nanoparticles

DPPC (dipalmitoylphosphatidylcholine) is a disaturated lipid capable of forming closely packed monolayers at the air–liquid interface of the lung and allows the surface tension within the alveoli to reduce to almost zero and thus prevent alveolar collapse. Carbon nanoparticles are formed in natural and man-made combustion events, including diesel engines, and are capable of reaching the alveolar epithelium during breathing. In this work, we have used Brewster angle microscopy and neutron reflectivity to study the effect of differing concentrations of carbon nanoparticles on the structure of DPPC monolayer as the monolayer is subject to compression and expansion. The results show that the inclusion of carbon nanoparticles within a DPPC monolayer affects the formation and structure of the lipid domains. The domains lose their circular structure and show a crenated structure as well as a reduction in overall size of the domains. This change in structure is also evident following expansion of the lipid monolayer, suggesting that some carbon nanoparticles may remain associated with the monolayer. This observation could have an important implication regarding the removal of nanosized airborne pollutants from the human lung

The Carnegie Astrometric Planet Search Program

We are undertaking an astrometric search for gas giant planets and brown dwarfs orbiting nearby low mass dwarf stars with the 2.5-m du Pont telescope at the Las Campanas Observatory in Chile. We have built two specialized astrometric cameras, the Carnegie Astrometric Planet Search Cameras (CAPSCam-S and CAPSCam-N), using two Teledyne Hawaii-2RG HyViSI arrays, with the cameras' design having been optimized for high accuracy astrometry of M dwarf stars. We describe two independent CAPSCam data reduction approaches and present a detailed analysis of the observations to date of one of our target stars, NLTT 48256. Observations of NLTT 48256 taken since July 2007 with CAPSCam-S imply that astrometric accuracies of around 0.3 milliarcsec per hour are achievable, sufficient to detect a Jupiter-mass companion orbiting 1 AU from a late M dwarf 10 pc away with a signal-to-noise ratio of about 4. We plan to follow about 100 nearby (primarily within about 10 pc) low mass stars, principally late M, L, and T dwarfs, for 10 years or more, in order to detect very low mass companions with orbital periods long enough to permit the existence of habitable, Earth-like planets on shorter-period orbits. These stars are generally too faint and red to be included in ground-based Doppler planet surveys, which are often optimized for FGK dwarfs. The smaller masses of late M dwarfs also yield correspondingly larger astrometric signals for a given mass planet. Our search will help to determine whether gas giant planets form primarily by core accretion or by disk instability around late M dwarf stars.Comment: 48 pages, 9 figures. in press, Publ. Astron. Soc. Pacifi

A prospective adaptive utility trial to validate performance of a novel urine exosome gene expression assay to predict high-grade prostate cancer in patients with prostate-specific antigen 2-10ng/ml at initial biopsy

BACKGROUND: Discriminating indolent from clinically significant prostate cancer (PCa) in the initial biopsy setting remains an important issue. Prospectively evaluated diagnostic assays are necessary to ensure efficacy and clinical adoption. OBJECTIVE: Performance and utility assessment of ExoDx Prostate (IntelliScore) (EPI) urine exosome gene expression assay versus standard clinical parameters for discriminating Grade Group (GG) ≥2 PCa from GG1 PCa and benign disease on initial biopsy. DESIGN, SETTING, AND PARTICIPANTS: A two-phase adaptive clinical utility study (NCT03031418) comparing EPI results with biopsy outcomes in men, with age ≥50 yr and prostate-specific antigen (PSA) 2-10ng/ml, scheduled for initial prostate biopsy. After EPI performance assessment during phase I, a clinical implementation document (ie, CarePath) was developed for utilizing the EPI test in phase II, where the biopsy decision is uncertain. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Performance evaluation of the EPI test in patients enrolled in phase I and publication of a consensus CarePath for phase II. RESULTS AND LIMITATIONS: In a total of 503 patients, with median age of 64 yr, median PSA 5.4ng/ml, 14% African American, 70% Caucasian, 53% positive biopsy rate (22% GG1, 17% GG2, and 15% ≥ GG3), EPI was superior to an optimized model of standard clinical parameters with an area under the curve (AUC) 0.70 versus 0.62, respectively, comparable with previously published results (n=519 patients, EPI AUC 0.71). Validated cut-point 15.6 would avoid 26% of unnecessary prostate biopsies and 20% of total biopsies, with negative predictive value (NPV) 89% and missing 7% of ≥GG2 PCa. Alternative cut-point 20 would avoid 40% of unnecessary biopsies and 31% of total biopsies, with NPV 89% and missing 11% of ≥GG2 PCa. The clinical investigators reached consensus recommending use of the 15.6 cut-point for phase II. Outcome of the decision impact cohort in phase II will be reported separately. CONCLUSIONS: EPI is a noninvasive, easy-to-use, gene expression urine assay, which has now been successfully validated in over 1000 patients across two prospective validation trials to stratify risk of ≥GG2 from GG1 cancer and benign disease. The test improves identification of patients with higher grade disease and would reduce the total number of unnecessary biopsies. PATIENT SUMMARY: It is challenging to predict which men are likely to have high-grade prostate cancer (PCa) at initial biopsy with prostate-specific antigen 2-10ng/ml. This study further demonstrates that the ExoDx Prostate (IntelliScore) test can predict ≥GG2 PCa at initial biopsy and defer unnecessary biopsies better than existing risk calculator\u27s and standard clinical data